Medigen Biotechnology Corp. 3176.TWO Stock
Medigen Biotechnology Corp. Price Chart
Medigen Biotechnology Corp. 3176.TWO Financial and Trading Overview
| Medigen Biotechnology Corp. stock price | 40.1 TWD |
| Previous Close | 33.7 TWD |
| Open | 34 TWD |
| Bid | 33.5 TWD x 0 |
| Ask | 33.7 TWD x 0 |
| Day's Range | 33.45 - 34 TWD |
| 52 Week Range | 28.5 - 48.95 TWD |
| Volume | 232.39K TWD |
| Avg. Volume | 182.49K TWD |
| Market Cap | 4.7B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.03 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
3176.TWO Valuation Measures
| Enterprise Value | 4.69B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.1418583 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Medigen Biotechnology Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -25.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 48.95 TWD |
| 52 Week Low | 28.5 TWD |
| 50-Day Moving Average | 33.72 TWD |
| 200-Day Moving Average | 34.5 TWD |
3176.TWO Share Statistics
| Avg. Volume (3 month) | 182.49K TWD |
| Avg. Daily Volume (10-Days) | 150.1K TWD |
| Shares Outstanding | 139.45M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 25.17% |
| % Held by Institutions | 2.81% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 7.59 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -4.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 15.734 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Medigen Biotechnology Corp.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No.3, Park Street |
| ZIP | 11503 |
| Phone | 886 2 7736 1234 |
| Website | https://www.medigen.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Medigen Biotechnology Corp., a biopharmaceutical company, focuses on the development of therapies for liver diseases and cancers in Taiwan. It offers cell therapies, such as MAGICELL-NK, which are natural killer cells; and MAGICELL-GDT, which are T cells. It also develops OBP-301 that has completed Phase I clinical trials in combination with radiation for the treatment of esophageal cancer in Japan; is in Phase I clinical trials in combination with immune checkpoint inhibitors (ICI) for patients with esophageal cancer in Japan; and in phase II study in combination with ICI for esophageal cancer and gastric cancer patients in the United States. Medigen Biotechnology Corp. was founded in 1999 and is headquartered in Taipei, Taiwan.
Q&A For Medigen Biotechnology Corp. Stock
What is a current 3176.TWO stock price?
Medigen Biotechnology Corp. 3176.TWO stock price today per share is 40.1 TWD.
How to purchase Medigen Biotechnology Corp. stock?
You can buy 3176.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medigen Biotechnology Corp.?
The stock symbol or ticker of Medigen Biotechnology Corp. is 3176.TWO.
Which industry does the Medigen Biotechnology Corp. company belong to?
The Medigen Biotechnology Corp. industry is Biotechnology.
How many shares does Medigen Biotechnology Corp. have in circulation?
The max supply of Medigen Biotechnology Corp. shares is 139.35M.
What is Medigen Biotechnology Corp. Price to Earnings Ratio (PE Ratio)?
Medigen Biotechnology Corp. PE Ratio is now.
What was Medigen Biotechnology Corp. earnings per share over the trailing 12 months (TTM)?
Medigen Biotechnology Corp. EPS is -4.03 TWD over the trailing 12 months.
Which sector does the Medigen Biotechnology Corp. company belong to?
The Medigen Biotechnology Corp. sector is Healthcare.